| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy
|
Quazi, Sameer
|
|
|
22 |
6 |
p. e392-e404
|
artikel
|
| 2 |
Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies
|
Hamadani, Mehdi
|
|
|
22 |
6 |
p. 373-381
|
artikel
|
| 3 |
Corrigendum to “OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4]
|
Ocio, Enrique
|
|
|
22 |
6 |
p. 425
|
artikel
|
| 4 |
Corrigendum to P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) Pages S152-S153]
|
Moreau, Philippe
|
|
|
22 |
6 |
p. 424
|
artikel
|
| 5 |
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma
|
Greuter, MJE
|
|
|
22 |
6 |
p. 382-392
|
artikel
|
| 6 |
Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia
|
Wang, Biao
|
|
|
22 |
6 |
p. 393-404
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
22 |
6 |
p. A1-A2
|
artikel
|
| 8 |
‘FLT3-ITD Mutation Does Not Influence Survival Outcome in Adult Acute Promyelocytic Leukemia Patients Treated With ATO and ATRA-Based Therapeutic Regimen: Experience From a North Indian Tertiary Care Centre’
|
Deka, Riju Rani
|
|
|
22 |
6 |
p. 416-423
|
artikel
|
| 9 |
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the Literature
|
El Hussein, Siba
|
|
|
22 |
6 |
p. e386-e391
|
artikel
|
| 10 |
Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia
|
Hassan, Naglaa M.
|
|
|
22 |
6 |
p. e376-e385
|
artikel
|
| 11 |
Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study
|
Abello, Virginia
|
|
|
22 |
6 |
p. e405-e413
|
artikel
|
| 12 |
SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions
|
Thomas, Sheeba K.
|
|
|
22 |
6 |
p. 347-355
|
artikel
|
| 13 |
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents?
|
Frustaci, Anna Maria
|
|
|
22 |
6 |
p. 356-361
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
22 |
6 |
p. A3-A4
|
artikel
|
| 15 |
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia
|
Song, Jinming
|
|
|
22 |
6 |
p. e414-e426
|
artikel
|
| 16 |
The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma
|
Nuvvula, Sri
|
|
|
22 |
6 |
p. 362-372
|
artikel
|
| 17 |
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program
|
Sacha, Tomasz
|
|
|
22 |
6 |
p. 405-415
|
artikel
|
| 18 |
The Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia
|
Shafik, Nevine F.
|
|
|
22 |
6 |
p. e363-e375
|
artikel
|
Tijdschrift beschrijving